Investor Relations

Press Releases

08/08/22
Conformis Reports Second Quarter 2022 Financial Results
BILLERICA, Mass. , Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2022 .
08/01/22
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
Agreement enables interested Vizient members, including academic medical centers, acute care facilities, and ambulatory surgery centers (ASCs), to purchase Conformis knee and hip replacement solutions, including its new Image-to-Implant® Platinum Services℠ Program BILLERICA, Mass. , Aug.
07/28/22
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
BILLERICA, Mass. , July 28, 2022 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti , Chief Executive Officer, and Bob Howe , Chief Financial Officer, will participate
07/05/22
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
BILLERICA, Mass. , July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the second quarter ended June 30, 2022 , after the market
05/24/22
Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity
As published in The Knee, new study supports Conformis’ longtime assertion that knee joint replacements that are fully personalized to each patient’s unique anatomy may be best to limit post-surgical pain and optimize patient satisfaction BILLERICA, Mass.
05/10/22
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference
BILLERICA, Mass. , May 10, 2022 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti , Chief Executive Officer, and Bob Howe , Chief Financial Officer, will participate
05/04/22
Conformis Reports First Quarter 2022 Financial Results
BILLERICA, Mass. , May 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2022 .
04/11/22
Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022
BILLERICA, Mass. , April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022 , before the market opens on Wednesday, May 4, 2022 , at approximately 7:00 a.m. Eastern Time .
04/01/22
Conformis, Inc. Appoints Michael Fillion as Chief Operating Officer
BILLERICA, Mass. , April 01, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Michael Fillion has joined the Company as its Chief Operating Officer. “We are pleased to announce the addition of Michael Fillion as Chief Operating Officer.
03/22/22
Conformis Partners with Synchrony to Offer CareCredit Financial Services to Orthopedic Patients
The partnership, announced at the 2022 AAOS conference, will enable patients that have selected a fully personalized Conformis implant – through the company’s Image-to-Implant Platinum Services Program – access to flexible payment options BILLERICA, Mass.
03/14/22
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
BILLERICA, Mass. , March 14, 2022 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS) announced today that Denise Pedulla has joined the Company as its Chief Legal Officer and Corporate Secretary. “We are pleased to announce the addition of Denise Pedulla as Chief Legal Officer and Corporate
03/11/22
Gary Fischetti nominated to join Conformis’ Board of Directors
BILLERICA, Mass. , March 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Gary P. Fischetti has been nominated to stand for election to the Company’s Board of Directors at the Company’s 2022 Annual Meeting of Stockholders, scheduled to be held on May 4, 2022 . Mr.
03/02/22
Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results
BILLERICA, Mass. , March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the fourth quarter and year ended December 31, 2021 .
03/02/22
Conformis Suspends All Distribution Operations and Business Development in Russia
BILLERICA, Mass. , March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), announced that it was suspending all distribution operations to Russia and any Russian-based entities for its orthopedic medical devices. Additionally, until further notice, the company will no longer pursue
02/28/22
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
Study included only patients with a fully personalized Conformis implant in one knee after previously receiving a competitive off-the-shelf implant in their other knee BILLERICA, Mass. , Feb. 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), the pioneer and leader of fully personalized
02/24/22
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel
Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass. , Feb. 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that
02/18/22
Conformis, Inc. to Participate in Upcoming Investor Conferences
BILLERICA, Mass. , Feb. 18, 2022 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti , Chief Executive Officer, and Bob Howe , Chief Financial Officer, will participate
01/20/22
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
BILLERICA, Mass. , Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business Update call on January 6, 2022 , it will release its financial results for the fourth quarter and fiscal year ended December 31, 2021 , after the market closes on
01/06/22
Conformis, Inc. Provides Business Update and Initial Expectations for 2022
Company Launches Innovative Image-to-Implant ® Platinum Services℠ Program to Better Serve Patients and Surgeons BILLERICA, Mass. , Jan. 06, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products,
01/04/22
Conformis, Inc. to Provide Business Update and Initial Expectations for 2022 on January 6, 2022
BILLERICA, Mass. , Jan. 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will provide a business update and initial expectations for 2022 before the market opens on Thursday, January 6, 2022 , at approximately 7:00 a.m. Eastern Time .